405 related articles for article (PubMed ID: 38612922)
1. Biological Basis of Breast Cancer-Related Disparities in Precision Oncology Era.
Neagu AN; Bruno P; Johnson KR; Ballestas G; Darie CC
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612922
[TBL] [Abstract][Full Text] [Related]
2. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
3. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.
Neagu AN; Whitham D; Bruno P; Arshad A; Seymour L; Morrissiey H; Hukovic AI; Darie CC
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338903
[TBL] [Abstract][Full Text] [Related]
4. The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology.
Hirko KA; Rocque G; Reasor E; Taye A; Daly A; Cutress RI; Copson ER; Lee DW; Lee KH; Im SA; Park YH
BMC Med; 2022 Feb; 20(1):72. PubMed ID: 35151316
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in breast cancer-does ethnicity matter?
Yap YS
ESMO Open; 2023 Jun; 8(3):101564. PubMed ID: 37290358
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Exposomics.
Neagu AN; Jayaweera T; Corrice L; Johnson K; Darie CC
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541726
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
[TBL] [Abstract][Full Text] [Related]
8. Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortality.
Moubadder L; Collin LJ; Nash R; Switchenko JM; Miller-Kleinhenz JM; Gogineni K; Ward KC; McCullough LE
Cancer; 2022 Sep; 128(18):3370-3382. PubMed ID: 35867419
[TBL] [Abstract][Full Text] [Related]
9. Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.
Newman LA; Kaljee LM
JAMA Surg; 2017 May; 152(5):485-493. PubMed ID: 28355428
[TBL] [Abstract][Full Text] [Related]
10. Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer.
Bottosso M; Mosele F; Michiels S; Cournède PH; Dogan S; Labaki C; André F
ESMO Open; 2024 Mar; 9(3):102247. PubMed ID: 38401248
[TBL] [Abstract][Full Text] [Related]
11. Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity.
McCall MK; Connolly M; Nugent B; Conley YP; Bender CM; Rosenzweig MQ
J Cancer Educ; 2020 Jun; 35(3):428-440. PubMed ID: 31392599
[TBL] [Abstract][Full Text] [Related]
12. Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.
Zajac KK; Malla S; Babu RJ; Raman D; Tiwari AK
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1779. PubMed ID: 36632988
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer under age 40: a different approach.
Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
[TBL] [Abstract][Full Text] [Related]
14. Toward Equitable Precision Oncology: Monitoring Racial and Ethnic Inclusion in Genomics and Clinical Trials.
García-Cárdenas JM; Indacochea A; Pesantez-Coronel D; Terán-Navas M; Aleaga A; Armendáriz-Castillo I; Peña Zúñiga L; Morán-Erazo C; Chávez-Vélez E; Pérez-Villa A; López-Cortés A; Guerrero S
JCO Precis Oncol; 2024 Apr; 8():e2300398. PubMed ID: 38662980
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
Miyashita M; Bell JSK; Wenric S; Karaesmen E; Rhead B; Kase M; Kaneva K; De La Vega FM; Zheng Y; Yoshimatsu TF; Khramtsova G; Liu F; Zhao F; Howard FM; Nanda R; Beaubier N; White KP; Huo D; Olopade OI
Breast Cancer Res; 2023 May; 25(1):58. PubMed ID: 37231433
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity.
Martini R; Newman L; Davis M
Clin Exp Metastasis; 2022 Feb; 39(1):7-14. PubMed ID: 33950410
[TBL] [Abstract][Full Text] [Related]
17. Integration of molecular pathology, epidemiology and social science for global precision medicine.
Nishi A; Milner DA; Giovannucci EL; Nishihara R; Tan AS; Kawachi I; Ogino S
Expert Rev Mol Diagn; 2016; 16(1):11-23. PubMed ID: 26636627
[TBL] [Abstract][Full Text] [Related]
18. Associations of Obesity, Physical Activity, and Screening With State-Level Trends and Racial and Ethnic Disparities of Breast Cancer Incidence and Mortality in the US.
Xie Z; Xie W; Liang Y; Lin H; Wu J; Cui Y; Su X; Zeng D
JAMA Netw Open; 2022 Jun; 5(6):e2216958. PubMed ID: 35699957
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Calip GS; Law EH; Ko NY
Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
[TBL] [Abstract][Full Text] [Related]
20. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
